Welcome to our dedicated page for DLH Holdings news (Ticker: $DLHC), a resource for investors and traders seeking the latest updates and insights on DLH Holdings stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect DLH Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of DLH Holdings's position in the market.
DLH Holdings Corp. (NASDAQ: DLHC) reported positive revenue growth and backlog strengthening in the second quarter of fiscal 2024. Revenue was $101.0 million, earnings were $1.8 million, EBITDA was $10.2 million, and total debt decreased to $170.8 million. Contract backlog rose to $736.2 million. Management expects continued growth and value enhancement through debt reduction. DLH continues to secure contracts, with a new VA CMOP program contract valued at $200 million.